Role of Exenatide in Type 1 Diabetes

Completed · Phase 2

Conditions studied: Type 1 Diabetes

In brief

The purpose of this study is to see if giving exenatide and insulin before a meal would lower blood sugars after the meal. This study may help in developing new treatments to help control high blood sugars after meals. This may help improve overall blood sugar control and prevent the long-term effects of diabetes.

Key facts

Study ID
NCT00456300
Run by
Montefiore Medical Center
People needed
11
Starts
2007-03-01
Expected to finish
2009-03-01
Last updated by the study team
2019-02-26

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.